HIGHLIGHTS
- who: Tapashi Dalvi and colleagues from the adjuvant chemotherapy in Denmark Clinical Epidemiology, Aarhus Hospital, Aarhus, Denmark, EpidStrategies, Rockville have published the research: Biomarker expression and survival in patients with non-small cell lung cancer receiving adjuvant chemotherapy in Denmark, in the Journal: PLOS ONE of March/22,/2023
- what: A prognostic impact for NSCLC patients receiving adjuvant chemotherapy was not associated with PD-L1 expression, or with EGFR and KRAS mutations.
- how: Tumor samples and biomarker assessment Using the Danish National Pathology Registry the authors identified FFPE tumor tissue samples from study . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.